Thase, M. E., Stanford, A. D., Memisoglu, A., Martin, W., Claxton, A., Bodkin, J. A., . . . Pathak, S. (2019). Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder. Neuropsychopharmacology.
Chicago-stil citatThase, Michael E., et al. "Results From a Long-term Open-label Extension Study of Adjunctive Buprenorphine/samidorphan Combination in Patients With Major Depressive Disorder." Neuropsychopharmacology 2019.
MLA-referensThase, Michael E., et al. "Results From a Long-term Open-label Extension Study of Adjunctive Buprenorphine/samidorphan Combination in Patients With Major Depressive Disorder." Neuropsychopharmacology 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.